The global iPSC Cell Therapies market size is predicted to grow from US$ 10180 million in 2025 to US$ 19920 million in 2031; it is expected to grow at a CAGR of 11.8% from 2025 to 2031.

Induced pluripotent stem cell (iPSC) cell therapy is a cutting-edge regenerative medicine technology that uses somatic cells to be converted into pluripotent stem cells through genetic reprogramming technology, and then differentiate into specific types of cells for the treatment of various diseases. This technology allows scientists to generate corresponding cells from the patients own cells, reducing the risk of immune rejection.

United States market for iPSC Cell Therapies is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.

China market for iPSC Cell Therapies is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.

Europe market for iPSC Cell Therapies is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.

Global key iPSC Cell Therapies players cover Bayer(BlueRock Therapeutics), Notch Therapeutics, Evotec Group, Pluristyx, Inc, Cellino, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2024.

LPI (LP Information) newest research report, the ?iPSC Cell Therapies Industry Forecast? looks at past sales and reviews total world iPSC Cell Therapies sales in 2024, providing a comprehensive analysis by region and market sector of projected iPSC Cell Therapies sales for 2025 through 2031. With iPSC Cell Therapies sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world iPSC Cell Therapies industry.

This Insight Report provides a comprehensive analysis of the global iPSC Cell Therapies landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on iPSC Cell Therapies portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms? unique position in an accelerating global iPSC Cell Therapies market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for iPSC Cell Therapies and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global iPSC Cell Therapies.

This report presents a comprehensive overview, market shares, and growth opportunities of iPSC Cell Therapies market by product type, application, key players and key regions and countries.

Segmentation by Type:

    Preclinical/Research Stage
    Clinical Stage
    Commercial Stage

Segmentation by Application:

    Neurodegenerative Diseases
    Cardiovascular Diseases
    Diabetes
    Other

This report also splits the market by region:

    Americas
        United States
        Canada
        Mexico
        Brazil
    APAC
        China
        Japan
        Korea
        Southeast Asia
        India
        Australia
    Europe
        Germany
        France
        UK
        Italy
        Russia
    Middle East & Africa
        Egypt
        South Africa
        Israel
        Turkey
        GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the companys coverage, product portfolio, its market penetration.

    Bayer(BlueRock Therapeutics)
    Notch Therapeutics
    Evotec Group
    Pluristyx, Inc
    Cellino
    Fate Therapeutics
    Allogene Therapeutics, Inc.
    Takeda Pharmaceutical Company Limited
    Century Therapeutics
    Resolution Therapeutics
    Kenai
    Garuda Therapeutics
    Hebecell
    Allele Biotechnology and Pharmaceuticals
    Aspen Neurosciencehttps://www.scispot.com/blog/top-innovative-stem-cell-companies-in-the-us
    ElevateBio
    iCamumo
    BeiGene, Ltd
    LumiSTAR Biotechnology
    Neukio Biotherapeutics
    Help Therapeutics
    Hopstem Biotechnology Inc.
    Nuwacell Biotechnologies Co., Ltd.
    ihan Biotech
    iRegene
    Allife Medicine
    CellOrigin
    XellSmart bio
    ThinkingBioMed
    Cell Inspire Bio
    Hema Cell
    Yuesai BIO
    Cytovia